You just read:

Proteostasis Therapeutics Receives Orphan Drug Designation in the EU for PTI-428 for the Treatment of Cystic Fibrosis

News provided by

Proteostasis Therapeutics, Inc.

Jun 04, 2019, 07:00 ET